Phase II Trial of Primary Radiation Therapy and Concurrent Chemotherapy for Patients with Locally Advanced Pancreatic Cancer-Reference-Cited by-同舟云学术

Phase II Trial of Primary Radiation Therapy and Concurrent Chemotherapy for Patients with Locally Advanced Pancreatic Cancer

Published:2005 Issue:4-6 Volume:68 Page:493-499
ISSN:0030-2414
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Magnino A.,Gatti M.,Massucco P.,Sperti E.,Faggiuolo R.,Regge D.,Capussotti L.,Gabriele P.,Aglietta M.

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference33 articles.

1. Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms

2. Evans DB, Abruzzese JL, Rich TA: Cancer of the pancreas; in De Vita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology (ed 4). Philadelphia, Lippincott, 1997, pp 1054-1087.

3. Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. The gastrointestinal tumor study group

4. Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial.

5. Protracted Venous Infusion 5-Fluorouracil With Concomitant Radiotherapy Compared With Bolus 5-Fluorouracil for Unresectable Pancreatic Cancer

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose-Response to Different Radiochemotherapy Regimens in Locally Advanced Pancreatic Cancer;IFMBE Proceedings;2019-09-25

2. Neoadjuvant therapy versus upfront surgery for potentially resectable pancreatic cancer: A Markov decision analysis;PLOS ONE;2019-02-28

3. Concurrent radiotherapy with oral fluoropyrimidine versus gemcitabine in locally advanced pancreatic cancer: a systematic review and meta-analysis;OncoTargets and Therapy;2015-11

4. Evaluation of low-dose fractionated radiation therapy as a chemopotentiator of gemcitabine in advanced pancreatic cancer: results from an international multi-institutional phase II trial;Journal of Radiation Oncology;2015-09-11

5. Multidisciplinary neoadjuvant management for potentially curable pancreatic cancer;Cancer Medicine;2015-03-13